valsartan plus hydrochlorothiazide

DRUG6 trials

Sponsors

Novartis

Conditions

HYPERTENSIONHypertensionMETABOLIC SYNDROMEPRE-HYPERTENSION

Phase 3

Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone

CompletedNCT00170989

NovartisHypertension

Start: 2004-09-30End: 2005-07-31Updated: 2011-11-08

VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil

CompletedNCT00171015

NovartisHypertension

Start: 2004-12-31End: 2005-04-30Updated: 2023-10-18

A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

CompletedNCT00250562

NovartisHypertension

Start: 2005-10-31End: 2006-06-30Updated: 2017-08-01

Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension

CompletedNCT00273299

NovartisHypertension

Start: 2005-11-30End: 2006-07-31Updated: 2011-11-08

Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

CompletedNCT00360178

NovartisHypertension

Start: 2006-07-31End: 2006-12-31Updated: 2016-11-18

Phase 4

A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome

CompletedNCT00170937

NovartisHYPERTENSION, METABOLIC SYNDROME, PRE-HYPERTENSION

Start: 2004-11-30Target: 507Updated: 2016-11-18

Related Papers

Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.

2008-06-2812 citations